Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Dr. Reddy's Laboratories Limited (RDY)

36.08   0.03 (0.08%) 06-24 16:02
Open: 36.1 Pre. Close: 36.05
High: 36.49 Low: 35.82
Volume: 197,065 Market Cap: 6124M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 36.507 - 36.728 36.728 - 36.939
Low: 35.298 - 35.558 35.558 - 35.807
Close: 35.683 - 36.064 36.064 - 36.43

Technical analysis

as of: 2019-06-24 4:31:00 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 44.66     One year: 46.40
Support: Support1: 35.82    Support2: 29.80
Resistance: Resistance1: 38.24    Resistance2: 39.73
Pivot: 37.41
Moving Average: MA(5): 36.58     MA(20): 37.60
MA(100): 39.03     MA(250): 36.38
MACD: MACD(12,26): -0.81     Signal(9): -0.72
Stochastic oscillator: %K(14,3): 7.73     %D(3): 13.05
RSI: RSI(14): 35.75
52-week: High: 42.82  Low: 29.00  Change(%): 8.7
Average Vol(K): 3-Month: 17105  10-Days: 18534

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
RDY has closed above bottom band by 16.3%. Bollinger Bands are 14.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 14 Jun 2019 23:24:12 Z
Dr. Reddy's Inks Deal to Sell Neurology Branded Products

Thu, 13 Jun 2019 22:06:42 Z
RDY Makes Notable Cross Below Critical Moving Average

Mon, 10 Jun 2019 23:11:36 Z
Dr. Reddy's Reports Positive Top-Line Data on Psoriasis Drug

Thu, 06 Jun 2019 17:11:39 Z
BioMarin's Vimizim Wins Nod in China for Rare Genetic Malady

Wed, 22 May 2019 14:14:22 Z
New Strong Sell Stocks for May 22nd

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 166.02
Shares Float (M) 120.89
% Held by Insiders
% Held by Institutions 13.64
Shares Short (K) 1510
Shares Short P. Month (K)

Stock Financials

EPS 1.400
EPS Est. Current Year 1.200
EPS Est. Next Year 1.810
EPS Est. Next Quarter
Forward EPS 1.#IO
Book Value (p.s.) 11.570
PEG Ratio
Profit Margin 12.22
Operating Margin
Return on Assets (ttm) 5.6
Return on Equity (ttm) 14.1
Qtrly Rev. Growth 13.6
Gross Profit (p.s.) 502.530
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 43.70
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E 25.77
P/E Growth Ratio
P/BV 3.12
P/S
P/CF

Dividends & Splits

Dividend 0.290
Dividend Yield 0.01
Dividend Pay Date 2018-08-09
Ex-Dividend Date 2018-07-13
Forward Dividend 0.290
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.